Status:
COMPLETED
Blocks Alternative to Sedation
Lead Sponsor:
Habib Khan
Collaborating Sponsors:
London Health Sciences Centre
Conditions:
Pacemaker Implantation
ICD Implantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Current practice is to implant cardiac electronic devices using intravenous sedation with midazolam and fentanyl, as well as local injection of anesthetic (1-2). However, some patients do not tolerate...
Detailed Description
Inpatients who are consented to have cardiac device implantation will be given study information as soon as the decision to implant a device is reached. The patients will have time to decide to partic...
Eligibility Criteria
Inclusion
- \> 18 years old,
- Undergoing cardiac device implantation in the suprapectoral area of the chest.
Exclusion
- Prior neck surgery ipsilateral to the device implantation site
- Infection over the injection site
- BMI ≥ 35
- Uncooperative patient
- Patient unable to provide consent
- Patient has a pre-existing implanted cardiac device in the left chest wall area
- Device implantation is booked in less than 2 hours.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04842227
Start Date
May 1 2021
End Date
March 31 2022
Last Update
April 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre Res. Inc. (Ont.)
London, Ontario, Canada, N6A 5A5